Amarin's omega-3 capsule, Vascepa, has the potential to treat millions of patients on traditional statins, says CEO John Thero.
Biopharmaceutical company Amarin is"just getting started" in treating cardiovascular patients, CEO John Thero told CNBC on Wednesday.
"We just doubled the size of our sales force. We will be applying next month to the FDA to get the expanded label," Thero said on"Power Lunch.""Assuming we get approved there, we'll further expand our sales force. There's tens of millions of patients who can potentially benefit from this therapy." The clinical trial showed Vascepa"could help improve heart health even more" for those patients already on traditional statins, Thero said. Statins lower cardiovascular risks by 25 percent to 35 percent, he said.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The C-Suite Insider: Hilton Hotels CEO says 'I'm not worried' about AirbnbThe C-Suite Insider: Hilton Hotels CEO says 'I'm not worried' about Airbnb.
Read more »
Southwest CEO says mechanics deserve new contract, but company wants 'flexibility'Southwest Airlines Co's mechanics, who have been in labor contract talks fo...
Read more »
As Ex-Enron CEO Exits Prison, Some of Company’s Old Businesses ThriveFormer Enron CEO Jeffrey Skilling re-enters a world in which some of the businesses built from his old company’s less appreciated assets have become formidable in their own right.
Read more »
Zillow CEO Spencer Rascoff Out Amid Pivot To Buying And Selling HomesZillow Group has announced that CEO Spencer Rascoff is out amid the company's pivot to buying and selling homes
Read more »
Elon Musk's promises about self-driving cars are 'almost unethical,' says AutoNation CEOTesla CEO Elon Musk's promises about autonomous vehicle technology are 'almost unethical,' AutoNation CEO Mike Jackson said in an interview with CNBC.
Read more »